Hot Biotech Stock
Conduct and
Ethics (the Code of Ethics) governing its directors, officers and employees. Within the time period required by the SEC, we will post on our website any modifications to the Code of Ethics, as required by the Sarbanes-Oxley Act of 2002.
more
Quintek Technologies, Inc. is a provider of back office services and solutions through out-sourcing and in-sourcing, consulting and solution sales. The company also sells hardware, software, and services for chemical-free desktop microfilm printers.
more
The Company is a
leading Life Science and High Technology company. The Company develops, manufactures, purchases and distributes the broadest range of high quality biochemicals and organic chemicals available in the world. These chemical products and kits are used
in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in ...
more
Panacos Pharmaceuticals, Inc. (which we refer to as we, Panacos or the Company) seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to
treat Human Immunodeficiency Virus, or HIV, and other major human viral diseases. We focus on disease indications where we believe there is a clear unmet medical need and ...
more
Telik, Inc. is a corporation that was incorporated in Delaware in 1988 and is a biopharmaceutical company working to discover, develop and commercialize
innovative small molecule drugs to treat diseases. We discovered our product candidates using our proprietary drug discovery technology, Target-Related Affinity Profiling, or TRAP, which we believe enables the rapid and efficient discovery of ...
more
,
Item
1A - Risk Factors ,
Item
7 - Management’s Discussion and Analysis of Financial Condition and Results of
Operations
and
Item
7A - Quantitative and Qualitative Disclosures about Market Risk ,
constitute “forward-looking statements” within the meaning of Section 27A of the
Securities Act of 1933, as ...
more
We are a biopharmaceutical development company dedicated to improving the lives of patients by developing novel protein, fully-human monoclonal antibody,
antibody-drug conjugate, and small molecule therapeutics for the treatment of cancer and cancer supportive care. We have taken a systematic approach to identifying and validating the most promising drug targets from our past research into the ...
more
We
were founded in 1971 and our shares began trading on The Nasdaq Stock Market in
1995. We are a leading supplier of instruments
for nanoscale imaging, analysis and prototyping to enable research, development
and manufacturing in a range of industrial, academic and research institutional
applications. In 2006, we completed our reorganization from product
divisions to market divisions. ...
more
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum — from
pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing — our installed base of over 200,000 systems provides essential biomedical ...
more
Our company is focused on the discovery, development, manufacture and
commercialization of therapeutic proteins for the treatment of human diseases. Our current therapeutic focus is in the areas of hemostasis, inflammatory and autoimmune diseases, cancer and viral infections. Our most advanced internal product
candidate, rhThrombin, which is being developed as a replacement for plasma-derived ...
more
We are a leading global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering
programs. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Our corporate mission is to help clients and partners maximize returns on their research and development ...
more
We are
a leading biotechnology company focused on the development and marketing of novel therapeutic and molecular diagnostic products. We employ a number of proprietary technologies that permit us to understand the genetic basis of human disease and the
role that genes and their related proteins play in the onset and progression of disease. We use this information to guide the development of ...
more
Services. Financial
information and results of operation for our operating segments are set forth
in Note 23 to the Notes to the Consolidated Financial Statements in Item 8, Part II
of this Annual Report on Form 10-K, and in Item 7, Management’s
Discussion and Analysis and Results of Operations—Operating Segment Results.
more
We are a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Our lead compound under development is Sulonex™ (sulodexide), which we previously referred to as KRX-101, a ...
more
Our relationship-based business model is central to our sustained growth and profitability. We aggressively pursue the development of long-term affiliations and
alliances with our clients. By working
more
